All In MedTech

Device Trial Radar · NCT03077516

Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease

Last checked: Nov 20, 2026Latest source record: Dec 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

216

Actual

Start

Nov 2016

Primary completion

Oct 31, 2019

Study completion Oct 31, 2019

Sponsor

Lead sponsor
LDR Spine USANot on our public-company list
Sponsor type
Industry
First posted
Mar 13, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate clinical and patient-reported outcomes at 10 years following surgery for a cohort of Mobi-C subjects treated on the IDE/Post Approval studies

Conditions

  • Cervical Disc Disease
  • Cervical Disc Degeneration

Interventions

  • Mobi-CDevice

    Device for cervical intervertebral disc replacement at one or two contiguous levels

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. NDI ScoreTime frame: 10 Years

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Orange County Neurosurgical Associates

    Laguna Hills, California

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.